What does CUSIP 695127100 represent in this 13F holders report?

CUSIP 695127100 is the security identifier for PCRX - Pacira BioSciences, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held PCRX - Pacira BioSciences, Inc. - Common Stock in Q2 2018?

148 institutional investors reported PCRX - Pacira BioSciences, Inc. - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

Pacira BioSciences, Inc. - Common Stock (PCRX)

CUSIP: 695127100

Q2 2018 13F Holders as of 30 Jun 2018

Security type / class: Equity / Common Stock
Shares outstanding: 40,532,351
Total 13F shares: 42,889,912
Share change: -686,855
Total reported value: $1,372,185,151
Put/Call ratio: 280%
Reported price per share: $32.05
Number of holders: 148
Value change: -$17,981,461
Number of buys: 73
Number of sells: 77

Security key

695127100

Report period

Q2 2018

Institutions

148

Top holders

PCRX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2018 Previous quarter: Q1 2018 Pacira BioSciences, Inc. SEC filings Pacira BioSciences, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 695127100

Newer quarter: Q3 2018 Previous quarter: Q1 2018

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of PCRX - Pacira BioSciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

VANGUARD GROUP INC

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2018

13F Lead comparable stake: 8.1% Showing 1-6 of 15 holder rows.

Rank 1 holder

VANGUARD GROUP INC

13F

Ownership: 8.1%
Position: $102.28M

13F

Rank 2 holder

BlackRock Finance, Inc.

13F

Ownership: 8%
Position: $100.55M

13F

Rank 3 holder

Consonance Capital Management LP

13F

Ownership: 6.5%
Position: $82.08M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	8.1%	$102,279,000 3,283,448 shares	—	31 Mar 2018
BlackRock Finance, Inc.	13F Company 13F	8%	$100,550,000 3,227,911 shares	—	31 Mar 2018
Consonance Capital Management LP	13F Company 13F	6.5%	$82,078,000 2,634,916 shares	—	31 Mar 2018
HealthCor Management, L.P.	13F Company 13F	5.7%	$71,645,000 2,300,000 shares	—	31 Mar 2018
PointState Capital LP	13F Company 13F	5%	$63,488,000 2,038,153 shares	—	31 Mar 2018
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	4.5%	$56,265,000 1,806,268 shares	—	31 Mar 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

148

42,889,912

Rows available

148

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

163

Q2 2018 holders

148

Holder diff

-15

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 value	Q2 2018 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend